← Back
$VRTX All transactions

VERTEX PHARMACEUTICALS INC / MA

F 10b5-1 Plan

$ Value

$736K

Shares

1,518

Price

$485

Filed

Feb 26

Insider

Name

Sachdev Amit

Title

EVP Chief Patient & Ext Af Off

CIK

0001406338

Roles

Officer

Transaction Details

Transaction Date

2026-02-24

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

57,416

Footnotes

Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 11/18/2025.

Filing Info

Accession No.

0000875320-26-000118

Form Type

4

Issuer CIK

0000875320

Sachdev Amit's History

Date Ticker Type Value
2026-02-25 VRTX $898K
2026-02-24 VRTX F $736K
2026-02-19 VRTX M $3.7M
2026-02-19 VRTX M $4.7M
2026-02-19 VRTX $427K
2026-02-19 VRTX $1.3M
2026-02-19 VRTX $861K
2026-02-19 VRTX $4.8M
2026-02-19 VRTX $9.2M
2026-02-19 VRTX $3.4M

Other Insiders at VRTX (90d)

Insider Bought Sold Last
SACHS BRUCE I 2026-04-15
WAGNER CHARLES F JR
EVP, CO & FO
2026-02-24
LEIDEN JEFFREY M
Executive Chairman
2026-02-24
Garber Alan M 2026-04-15
Sachdev Amit
EVP Chief Patient & Ext Af Off
$28.4M 2026-02-25
Upadhyay Suketu 2026-04-15
ALTSHULER DAVID
EVP, Chief Scientific Officer
2026-01-22
Bhatia Sangeeta N. $133K 2026-02-13
Kewalramani Reshma
CEO & President
$19.7M 2026-02-27
Biller Jonathan
EVP and Chief Legal Officer
$3.6M 2026-02-25
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
$1.6M 2026-02-25
Bozic Carmen
EVP and CMO
$3.3M 2026-03-27
Liu Joy
EVP and Chief Legal Officer
$882K 2026-04-01
Ambrose Kristen
SVP & Chief Accounting Officer
$2.0M 2026-02-26
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
$2.5M 2026-02-25
McKechnie Duncan
EVP, Chief Commercial Officer
$4.9M 2026-03-11
Bunnage Mark E.
EVP, Chief Scientific Officer
$3.0M 2026-02-25